A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome

被引:48
作者
Bates, Sylvia M.
Hill, Valerie A.
Anderson, John B.
Chapple, Christopher R.
Spence, Rosemary
Ryan, Claire
Talbot, Martin D.
机构
[1] Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England
[2] Royal Hallamshire Hosp, Dept Urol, Sheffield S10 2JF, S Yorkshire, England
关键词
prostatitis; prostatodynia; chronic pelvic pain syndrome; corticosteroids;
D O I
10.1111/j.1464-410X.2007.06667.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVES To assess the validity of our observational experience that a short course of oral prednisolone therapy might be of value in the management of symptoms of chronic pelvic pain syndrome (CPPS) in men. PATIENTS AND METHODS Twenty-one men with CPPS (inflammatory or non-inflammatory) for >= 6 months, and who had failed to improve with standard antibiotic therapy, were randomized to receive either a 1-month reducing course of oral prednisolone (nine) or an equivalent placebo regimen (12 men). The outcome measures used were the McGill Pain Questionnaire, the Hospital Anxiety and Depression Scale (HADS), General Health Questionnaire-30 (GHQ-30) and the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI), which were completed at baseline and 3 months. RESULTS Outcomes were analysed for the 18 patients (six treated, 12 placebo) who completed the 3 months of follow-up. At both baseline and 3 months, respectively, there was no statistically significant difference between the groups in the NIH-CPSI total score (P = 0.48 and 0.62; Mann-Whitney U-test), or in the HADS (anxiety, P = 0.85 and 0.67; depression P = 0.96 and 0.74), and there was no significant improvement or deterioration over time. Although not statistically significant, there was a trend to improvement in the depression score for the active group (P = 0.13). However, the clinical significance is doubtful, as both baseline and follow-up depression scores were within the normal range. No patient had clinically negative changes in depression. A 3-month follow-up analysis was not possible for the McGill Pain Questionnaire or GHQ-30 as not all patients completed the questionnaire. CONCLUSIONS Whilst the study showed no clinical benefit of using corticosteroids in the management of CPPS, the few patients recruited limited the validity of firm conclusions from the data. There was a trend towards an improvement of depression levels amongst subjects. The study highlights the difficulties of recruitment and illustrates the complex psychological profiles of patients with CPPS.
引用
收藏
页码:355 / 359
页数:5
相关论文
共 19 条
[1]
Autoimmune prostatitis: Evidence of T cell reactivity with normal prostatic proteins [J].
Alexander, RB ;
Brady, F ;
Ponniah, S .
UROLOGY, 1997, 50 (06) :893-899
[2]
Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis chronic pelvic pain syndrome [J].
Alexander, RB ;
Ponniah, S ;
Hasday, J ;
Hebel, JR .
UROLOGY, 1998, 52 (05) :744-749
[3]
Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one non-responder [J].
Bates, S ;
Talbot, M .
SEXUALLY TRANSMITTED INFECTIONS, 2000, 76 (05) :398-399
[4]
STUDIES ON THE ROLE OF UREAPLASMA-UREALYTICUM AND MYCOPLASMA-HOMINIS IN PROSTATITIS [J].
BRUNNER, H ;
WEIDNER, W ;
SCHIEFER, HG .
JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (05) :807-813
[5]
A SEARCH FOR INFECTIOUS AGENTS IN CHRONIC ABACTERIAL PROSTATITIS USING ULTRASOUND GUIDED BIOPSY [J].
DOBLE, A ;
THOMAS, BJ ;
FURR, PM ;
WALKER, MM ;
HARRIS, JRW ;
WITHEROW, RO ;
TAYLORROBINSON, D .
BRITISH JOURNAL OF UROLOGY, 1989, 64 (03) :297-301
[6]
GRAHAMESMITH DG, 2002, OXFORD TXB CLIN PHAR, P514
[7]
NIH consensus definition and classification of prostatitis [J].
Krieger, JN ;
Nyberg, L ;
Nickel, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03) :236-237
[8]
The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure [J].
Litwin, MS ;
McNaughton-Collins, M ;
Fowler, FJ ;
Nickel, JC ;
Calhoun, EA ;
Pontari, MA ;
Alexander, RB ;
Farrar, JT ;
O'Leary, MP .
JOURNAL OF UROLOGY, 1999, 162 (02) :369-375
[9]
TREATMENT OF PROSTATITIS IN THE RAT [J].
LUNDGREN, R ;
HOLMQUIST, B ;
HESSELVIK, M ;
MUNTZING, J .
PROSTATE, 1984, 5 (03) :277-284
[10]
McNaughton C, 2001, COCHRANE DB SYST REV, V1